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Excess fatty acid accumulation in nonadipose tissues is a hallmark of metabolic disease. When elevated lipid
levels exceed the cell’s capacity to store or utilize fatty acids, a lipotoxic-response is elicited, characterized
by destruction of organelle membranes, activation of stress pathways, and apoptosis. This Minireview
focuses on the mechanisms by which lipid overload causes nonadipose cell death and contributes to the
pathogenesis of obesity and diabetes.What Is Lipotoxicity?
The prevalence of obesity, metabolic syndrome, and diabetes
worldwide is a significant health problem due to serious medical
complications that include cardiovascular disease and renal
failure. In these diseases, elevated serum triglycerides (TAG)
and free fatty acids (FFAs) cause lipid accumulation in nonadi-
pose tissues, including the pancreas, heart, liver, kidney, and
blood vessel wall. While FFAs and their metabolites play a key
role in membrane structure, intracellular signaling and energy
homeostasis, accumulation of excess lipid in these organs
causes cell dysfunction and cell death. This process, termed
lipotoxicity, has been implicated in b cell loss during the progres-
sion of type 2 diabetes—and in the pathogenesis of diabetic
complications through loss of cardiomyocytes, hepatocytes,
renal parenchymal cells, and endothelial cells.
Lipotoxicity has been studied in animal models, which support
a link between ectopic lipid accumulation, cell death, and organ
dysfunction. In rodent models with impaired leptin signaling,
elevated circulating FFA levels precede the onset of diabetes
and heart failure and are associated with steatosis and subse-
quent apoptosis of b cells and cardiac myocytes, respectively
(Lee et al., 1994; Zhou et al., 2000). Dietary and pharmacological
interventions that decrease lipid accumulation mitigate the
progression to diabetes and heart failure, suggesting a causal
role for lipotoxicity in the pathogenesis of metabolic disease.
While the applicability of findings from leptin-deficient models to
human obesity and diabetes has been debated, lipid accumula-
tion and cell death in nonadipose tissues of murine models of
diet-induced obesity are consistent with a role for lipid accumula-
tion in thepathogenesis of organdysfunction (Park et al., 2005). In
each of thesemodels, however, it has been difficult to distinguish
complications that result from excess lipids alone versus the
combination of hyperlipidemia, hyperglycemia, and insulin resis-
tance. Insight into the specific consequences of nonadipose
tissue lipid overload has come from transgenic animal models in
which lipid uptake into tissues has been increased by expression
of proteins that facilitate lipid delivery, despite normal systemic
glucose and FFA metabolism. For example, overexpression of
lipoprotein lipase or long chain acyl CoA synthetase causes lipid
accumulation in the heart and results in heart failure (Chiu et al.,
2001; Yagyu et al., 2003), supporting the hypothesis that lipids
contribute to cardiac dysfunction in metabolic diseases.
Recent studies extend the link between ectopic lipid accumu-
lation in the myocardium and heart failure to human metabolicdiseases. For example, in obese subjects, intramyocellular
triglyceride can be detected noninvasively and is associated
with early abnormalities of cardiac function (Szczepaniak et al.,
2003). Furthermore, in endstage heart failure, histological exam-
ination reveals lipid accumulation in hearts from diabetic and
obese patients (Sharma et al., 2004).
To gain insight into mechanisms of lipid-induced cell death,
investigators have studied the response of cultured cells to
supplementation of growth media with excess FFAs complexed
to albumin. In a dose-dependent manner, long-chain saturated
FFAs (i.e., palmitate) induce apoptosis in a variety of established
cell lines and primary cell types, including endothelial cells, fibro-
blasts, pancreatic b cells, hepatocytes, and myocytes. This
response is enhanced by high glucose to model the pathophysi-
ological hyperglycemia that often accompanies hyperlipidemia
(i.e., glucolipotoxicity) (El-Assaad et al., 2003). While excess
FFAs induce many cellular signaling and metabolic pathways
(e.g., insulin signaling), wewill focus in thisMinireview on insights
into themechanisms of lipotoxic cell death. Oxidized lipoproteins
and free cholesterol can also induce cell death, but consideration
of these other lipid mediators is beyond the scope of this review.
Lipid Metabolites
Cell death is induced by supplementation of culture media with
long-chain saturated FFAs at concentration ranges that model
pathophysiological conditions, but similar concentrations of
unsaturated long-chain FFAs are well tolerated (de Vries et al.,
1997; Listenberger et al., 2003; Maedler et al., 2003). Cotreat-
ment with saturated and unsaturated long-chain FFAs rescues
cells from lipotoxicity. While both saturated and unsaturated
exogenous long-chain FFAs are directed to the mitochondria
for b oxidation and to the endoplasmic reticulum (ER) for
complex lipid synthesis, only long-chain saturated fatty acyl
CoAs serve as substrates for de novo ceramide synthesis,
a specificity that is dictated by the enzymes serine palmitoyl-
transferase and ceramide synthase.
Ceramide is a lipid second messenger involved in initiation of
apoptosis by stimuli such as heat shock and ionizing radiation.
Increased ceramide levels are observed in pancreatic islets
of ZDF rats and in hearts ofMHC-ACSmice (Chiu et al., 2001; Shi-
mabukuro et al., 1998). In vitro studies have demonstrated that,
under lipotoxic conditions, increased de novo ceramide synthesis
is a result of increased substrate availability (Listenberger et al.,
2001; Shimabukuro et al., 1998). Thus, ceramide may contributeCell Metabolism 10, July 8, 2009 ª2009 Elsevier Inc. 9
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death. Nonetheless, inhibiting de novo ceramide synthesis
prevents lipotoxicity in b cells but not fibroblasts, suggesting that
cell type-specificmetabolic channeling of FFAsmay be important.
Long-chain FFAs are also key precursors in phospholipid
biosynthesis. Supplementation of rat cardiomyocyteswith palmi-
tate leads to remodeling of phosphaditic acid from a species
containingonesaturatedandoneunsaturatedacyl chain todipal-
mitoyl phosphatidic acid,which is not abundant under physiolog-
ical conditions (Ostrander et al., 2001). This species is a poor
substrate for cardiolipin biosynthesis, leading to depletion of
cellular cardiolipin, disruption of the mitochondrial inner
membrane, and release of cytochrome c. Saturated FFAs may
also cause alterations in other mitochondrial membrane phos-
pholipids and production of reactive oxygen species (ROS),
leading to mitochondrial dysfunction. Profound alterations in ER
membrane phospholipids also occur under lipotoxic conditions.
Inmetabolic labelingstudies, 3H-palmitate is rapidly incorporated
into phosphatidylcholine in the ER, leading to a significant
increase in the saturation of ERmembrane phospholipids relative
to untreated cells (Borradaile et al., 2006b). These changes are
followed by ER swelling and escape of the protein-folding chap-
erones Grp78 and PDI to the cytosol, suggesting that saturated
FFAs compromise ER membrane structure and integrity.
Oxidative Stress
Under physiological conditions, ROS participate in cellular
signaling and overall, cellular ROS levels are kept in check by
enzymatic scavengers (e.g., dismutases and peroxidases) and
redox-sensitive modulators (e.g., vitamin E and glutathione). In
pathophysiolgical conditions, ROS generation may exceed
cellular antioxidant defenses, resulting in oxidative damage of
proteins, lipids, and DNA. Oxidative stress can impair membrane
integrity, organelle function, and regulation of gene expression,
thereby contributing to cell death.
Both human and animal studies suggest that oxidative stress is
involved in the response to lipid overload. DNA and protein
oxidation products, pro-oxidants, and glutathione disulfide are
elevated in the serum and b cells of type 2 diabetics with hyper-
lipidemia. Similarly in the ob/ob, db/db, and AY mouse models,
and in streptozotocin-treated mice, markers of oxidative stress
are increased concomitant with lipid accumulation. Organ-
specific overexpression of enzymatic scavengers (e.g., super-
oxide dismutase) or systemic administration of antioxidants
(e.g., a-lipoic acid) improves end organ function in diabetic and
transgenic lipotoxicity mouse models (Lee et al., 2006; Ye et al.,
2004). In cell culture models of lipotoxic stress, supplementation
of growthmediawithpalmitate producesROSand treatmentwith
antioxidants inhibits FFA-induced caspase-3 activation, ER
dysfunction, and cell death (Borradaile et al., 2006a; Listenberger
et al., 2001). Together, these findings are consistent with a role
for oxidative stress in the pathogenesis of lipotoxicity.
ER Stress
The ER is central to the regulation of both lipid and protein
metabolism. Conditions that disrupt ER homeostasis or mis-
folded mutant proteins activate the ER stress response. This
initially inhibits protein synthesis to prevent further overloading
of the ER and induces chaperones to aid in the refolding of mis-10 Cell Metabolism 10, July 8, 2009 ª2009 Elsevier Inc.folded proteins. However, prolonged or extreme ER stress over-
whelms the cell, triggering activation of pro-apoptotic genes
(e.g., CHOP) and inducing oxidative stress.
Lipids can also initiate ER stress. Supplementation of cultured
fibroblasts, myoblasts, and b cells with saturated FFAs in vitro
leads to alterations in ERstructure and function that precede acti-
vation of the ER stress response, suggesting that lipid incorpora-
tion into this organelle may contribute to initiation of ER stress
(Borradaile et al., 2006b; Moffitt et al., 2005). While lipid-induced
ER stress may initially be cytoprotective (Cnop et al., 2007), pro-
longed FFA-induced ER stress promotes cell death. In the livers
and adipose tissues of ob/ob and high-fat-diet-induced (HFD)
mouse models of obesity, transcription of the ER chaperone
Grp78 is increased and PERK is activated (Ozcan et al., 2004).
Inhibition of FA-induced ER stress with chemical ER chaperones
improves insulin signaling and diminishes systemic insulin resis-
tance in ob/ob mice (Ozcan et al., 2006). In a model of nonalco-
holic fatty liver disease, rats fed a high saturated FFA diet show
Grp78 and CHOP induction and caspase-3 activation following
lipid accumulation in the liver (Wang et al., 2006). Furthermore,
knockout of the proapoptotic transcription factor CHOP in db/
db and HFD mice increases b cell mass and function and
prevents hyperglycemia and glucose intolerance in the setting
of obesity (Song et al., 2008). These studies and others have
suggested that chronic lipid-induced ER stress is detrimental.
Molecular Mechanisms that Link Lipids to Stress
Emerging evidence implicates both oxidative and ER stress
responses in lipotoxicity, yet distinct molecular pathways linking
FFA overload to these stress responses are not well character-
ized. To uncover specific mechanisms, investigators have
probed signaling pathways and carried out expression array
analyses, proteomics, lipidomics, and genetic screens. Collec-
tively, these studies suggest that a number of downstream
pathways involving enzymes, signaling molecules, and noncod-
ing RNAs (ncRNAs) act in concert to direct lipid-overloaded,
damaged cells to die (Figure 1). In vivo, the functions of these
mediators of lipotoxicity are amplified by signaling pathways
downstream of Toll-like receptor 4 and the insulin receptor,
both of which are modulated by pathophysiological lipid levels.
There are several mechanisms through which lipotoxicity may
induce oxidative stress. The FFAmetabolite ceramide can activate
NADPH oxidase and disrupt mitochondrial respiration, either by
inducing release of cytochrome c or through interaction with mito-
chondrial respiratory chain complex III. However, FFA-induced
ROSproduction can occur even in the absence of de novo ceram-
ide biosynthesis, implicating other mechanisms (Listenberger
etal., 2001).ExcessFFAsalso increasediacylglycerol (DAG),which
activates NADPH oxidase through PKC-dependent pathways
(Inoguchi et al., 2000). Inhibition of NADPH oxidase activity, by
overexpressionofdominant negativeRAC1orp67mutants,blocks
FFA-induced apoptosis (Cacicedo et al., 2005). Increased FFA
oxidation and the attendant increases in oxidative phosphorylation
also have the potential to produce singlet electrons, contributing to
oxidative stress. It has also been proposed that FFA remodeling of
mitochondrial membranes leads to organelle dysfunction that
causes or amplifies oxidative stress. Moreover, extreme or pro-
longed ER stress leads to oxidative stress. Lipid-induced oxidative
stress may involve a combination of these pathways.
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organelle or by indirect activation of upstream mediators.
Adverse physiochemical properties of saturated triglyceride
that accumulates in the ER may disrupt the architecture of this
organelle (Moffitt et al., 2005). Alternatively, remodeling of ER
membrane lipids by increased saturation of ER membrane acyl
chain composition is predicted to favor a thicker, less fluid
bilayer structure andmay profoundly alter the function of ER inte-
gral membrane proteins and membrane function (Borradaile
et al., 2006a). Indirectly, lipid-induced ROS may trigger ER
stress, since pretreatment of cardiomyoblasts with the antioxi-
dant a-tocopherol (vitamin E) inhibits palmitate-induced ROS
generation and attenuates Grp78 and CHOP induction. None-
theless, the precise mechanism by which oxidative stress leads
to ER stress has yet to be determined.
The importance of oxidative and ER stress in the lipotoxic
response is underscored by the observation that, in a genetic
screen, loss-of-function mutations in genes that disrupt oxidative
and ER stress inhibit lipotoxic cell death. Retroviral promoter trap
mutagenesis of Chinese hamster ovary cells led to the isolation of
mutantsdisrupted in the expressionof eukaryotic elongation factor
1A-1 (eEF1A-1) and the ncRNA gadd7, both of which are induced
by lipotoxic stress (Borradaile et al., 2006a; Brookheart et al.,
2009). eEF1A-1 is critical for palmitate- and non-lipid-induced ER
stress, possibly through its role in regulation of the length and
stability of actin filaments. Gadd7 serves as a feed-forward regu-
lator of palmitate-induced and generalized oxidative stress.
Additional insights into molecular mechanisms of lipotoxicity
have come from studies that compare the response of cultured
cells to toxic saturated long-chainFFAsand less-toxicunsaturated
FFAs. Transcript profiling of cells treated with palmitate versus
oleate demonstrates significant changes in expression of many
genes, although the functional role of such changes is unknown.
Signaling molecules that are differentially activated by palmitate
and oleate include PKC-d andNF-kB, and inhibition of these path-
ways prevents cell death in insulinoma and retinal pericytes,
Figure 1. The Lipotoxic Response
In nonadipose cells, excess saturated FFAs
induce oxidative and ER stress through lipid
metabolites and signaling pathways. Dysfunction
of mitochondria and the ER are key steps through
which excess lipid induces cell death, whereas
channeling of excess FFAs to lipid droplets is cyto-
protective.
respectively (Cacicedo et al., 2005; Eitel
et al., 2003). By contrast, FFA-induced
b cell death is NF-kB independent (Khar-
roubi et al., 2004). A number of studies
have implicated a role for JNK, but it
remains uncertain whether this kinase is
an activator or executor of the lipotoxic
response.
Pathways that Modulate
Lipotoxicity
Molecular pathways that channel FFAs to
alternate fates can protect cells from lip-
otoxicity. Cosupplementation of cells with exogenous saturated
and unsaturated FFAs or overexpression of stearoyl CoA desa-
turase 1 leads to more efficient incorporation of exogenous
palmitate into TAG stores and prevents lipotoxic cell death
(Listenberger et al., 2003; Maedler et al., 2003). Precisely why
unsaturated FFAs favor TAG synthesis and storage is not known.
Overexpression of DAG acyltransferase 1 (Dgat1) in skeletal
muscle increases TAG stores, decreases DAG and ceramide,
and restores insulin sensitivity in HFD mice (Liu et al., 2007).
Conversely, Dgat1/ fibroblasts have increased susceptibility
to lipotoxicity. Together, these studies suggest that diversion
of excess lipid to neutral lipid droplets is initially protective in
the setting of lipotoxic stress. However, either because lipid
storage capacity is exceeded, or because TAGs are eventually
hydrolyzed, toxic lipids can still become available to disrupt
cellular function even in the face of increased TAG stores.
The net effect of channeling excess FFAs to the mitochondria
for b oxidation is less clear. In culturedmyoblasts and endothelial
cells, activation of AMP kinase, which increases b oxidation,
diminishes palmitate-induced activation of NF-kB, apoptosis,
and cell death (Borradaile et al., 2006b; Cacicedo et al., 2004).
Conversely, it has been proposed that increased rates of flux
oxidative phosphorylation cycles overwhelms the metabolic
machinery, generating increased levels of the free radical super-
oxide and thus oxidative stress. Under lipotoxic conditions,
incomplete b oxidation contributes to insulin resistance and
may play a role in signals for lipotoxic cell death (Koves et al.,
2008). The functional state of the mitochondria is likely an impor-
tant determinant of whether b oxidation is protective or harmful in
lipotoxicity.
Conclusion
Anunderstandingof themolecular eventsof lipotoxic stress isnow
beginning to emerge from the study of animal models of diabetes
and obesity and from cell-culture models of lipid overload. FFAs
induce oxidative and ER stress through alterations of organelleCell Metabolism 10, July 8, 2009 ª2009 Elsevier Inc. 11
Cell Metabolism
Minireviewmembrane structure/function, production of toxic metabolites,
and activation of signaling pathways. Although important insights
have been gained from simplified in vitro approaches, findings
from these studies require extension to in vivo models of patho-
physiology. Combining these approaches, future studies of the
molecular mechanisms of lipotoxicity will provide insight into the
pathogenesis of complications of diabetes and obesity.
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